** Shares of Immuron IMC.AX rise as much as 10.5% to
A$0.095, their highest since June 3
** Stock posts its biggest intraday pct gain since April 10
** Biopharmaceutical co posts FY24 global sales of A$4.9 mln
($3.32 mln), up 174% on pcp
** Says achieved record FY24 sales in the United States with
A$1.1 mln, up 74% from the previous year
** Says it hopes to achieve strong North American growth in
FY25 on the back of planned increased brand investment and
distribution
** More than 943,200 shares change hands, compared with the
30-day average volume of 136,929
** Stock had risen 11.7% this year, as of last close
($1 = 1.4767 Australian dollars)
(Reporting by Sneha Kumar in Bengaluru)
((Sneha.Kumar@thomsonreuters.com;))